Compare · BIMI vs COR
BIMI vs COR
Side-by-side comparison of BIMI International Medical Inc. (BIMI) and Cencora Inc. (COR): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIMI and COR operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- COR is the larger of the two at $53.33B, about 3834.6x BIMI ($13.9M).
- Over the past year, BIMI is up 0.0% and COR is down 3.5% - BIMI leads by 3.5 points.
- COR has hit the wire 5 times in the past 4 weeks while BIMI has been quiet.
- COR has more recent analyst coverage (25 ratings vs 0 for BIMI).
- Company
- BIMI International Medical Inc.
- Cencora Inc.
- Price
- $0.31-36.58%
- $274.18-0.32%
- Market cap
- $13.9M
- $53.33B
- 1M return
- +0.00%
- +7.28%
- 1Y return
- +0.00%
- -3.46%
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 5
- Recent ratings
- 0
- 25
BIMI International Medical Inc.
BOQI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. It offers prescription and over-the-counter drugs, nutritional supplements, health foods, and sundry products, as well as traditional Chinese medicines, personal and family care products, and miscellaneous items under the Lijiantang Pharmacy brand name. The company also provides IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as NF Energy Saving Corporation and changed its name to BOQI International Medical Inc. in December 2019. BOQI International Medical Inc. was incorporated in 2000 and is based in Dalian, the People's Republic of China.
Cencora Inc.
CoreSite Realty Corporation (NYSE:COR) delivers secure, reliable, high-performance data center, cloud access and interconnection solutions to a growing customer ecosystem across eight key North American markets. More than 1,375 of the world's leading enterprises, network operators, cloud providers, and supporting service providers choose CoreSite to connect, protect and optimize their performance-sensitive data, applications and computing workloads. Our scalable, flexible solutions and 460+ dedicated employees consistently deliver unmatched data center options  all of which leads to a best-in-class customer experience and lasting relationships.
Latest BIMI
- BIMI International Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Director Oudom Fnu was granted 1,123,500 shares, increasing direct ownership by 285% to 1,518,243 units (SEC Form 4)
- BIMI International Medical Inc. filed SEC Form 8-K: Leadership Update
- 12 Health Care Stocks Moving In Monday's After-Market Session
- BIMI International Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Latest COR
- Cencora Inc. filed SEC Form 8-K: Leadership Update, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
- SEC Form SD filed by Cencora Inc.
- Director Durcan Dermot Mark bought $1,065,040 worth of shares (4,000 units at $266.26), increasing direct ownership by 17% to 27,767 units (SEC Form 4)
- Cencora Appoints Eva Boratto as Executive Vice President and Chief Financial Officer
- Cencora Announces Updated Fiscal Year 2026 Financial Outlook
- SEC Form 10-Q filed by Cencora Inc.
- Cencora Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
- Cencora Reports Fiscal 2026 Second Quarter Results
- Director Tyler Lauren M was granted 99 shares, increasing direct ownership by 3% to 3,809 units (SEC Form 4)
- Director Cooper Ellen was granted 99 shares, increasing direct ownership by 14% to 796 units (SEC Form 4)